← Leaderboards
Anil Kottam
Bridgesource Medical Corporation
$1,955,638
Attributed
$1,955,638
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $958.9K · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$1,955,638 · 1
By mechanism
R44$1,955,638 · 1
Top collaborators
No co-investigators on record.
Most similar at Bridgesource Medical Corporation
Same institution · by research overlap
- John E Porterfield$8,055,507
Others in their field
Other Emerging Leaders on “Dangerousness”
- Timothy M Willson · University Of Cape Town$32,741,597
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$7,830,490
- Gary Kobinger · University Of Texas Med Br Galveston$7,131,815
- Donald R Gehlert · Epiodyne, Inc.$6,552,597
- William K Schmidt · Epiodyne, Inc.$6,552,597
- Mark E J Sheffield · University Of Chicago$5,397,638
Research focus
DangerousnessDesignAging PopulationAged, 80 And OverAcute Kidney FailureAge RelatedBlood VolumeBypassCardiacAmericanAnimalsCardiac VolumeCardiovascular SystemCaregiversCathetersChestClinical EfficacyClinically ActionableClinical ResearchClinical TrialsCardiac Surgery ProceduresConnective TissueCoronaryDetection